Literature DB >> 16240321

Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism.

Andrew B Strawbridge1, Jeffrey S Elmendorf.   

Abstract

Endothelin-1 (ET-1) disrupts insulin-regulated glucose transporter GLUT4 trafficking. Since the negative consequence of chronic ET-1 exposure appears to be independent of signal disturbance along the insulin receptor substrate-1/phosphatidylinositol (PI) 3-kinase (PI3K)/Akt-2 pathway of insulin action, we tested if ET-1 altered GLUT4 regulation engaged by osmotic shock, a PI3K-independent stimulus that mimics insulin action. Regulation of GLUT4 by hyperosmotic stress was impaired by ET-1. Because of the mutual disruption of both insulin- and hyperosmolarity-stimulated GLUT4 translocation, we tested whether shared signaling and/or key phosphatidylinositol 4,5-bisphosphate (PIP2)-regulated cytoskeletal events of GLUT4 trafficking were targets of ET-1. Both insulin and hyperosmotic stress signaling to Cbl were impaired by ET-1. Also, plasma membrane PIP2 and cortical actin levels were reduced in cells exposed to ET-1. Exogenous PIP2, but not PI 3,4,5-bisphosphate, restored actin structure, Cbl activation, and GLUT4 translocation. These data show that ET-1-induced PIP2/actin disruption impairs GLUT4 trafficking elicited by insulin and hyperosmolarity. In addition to showing for the first time the important role of PIP2-regulated cytoskeletal events in GLUT4 regulation by stimuli other than insulin, these studies reveal a novel function of PIP2/actin structure in signal transduction. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16240321      PMCID: PMC2409058          DOI: 10.1002/jcb.20687

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  55 in total

1.  Elevated plasma endothelin in patients with diabetes mellitus.

Authors:  K Takahashi; M A Ghatei; H C Lam; D J O'Halloran; S R Bloom
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

2.  Endothelin-1 induces insulin resistance in conscious rats.

Authors:  C C Juan; V S Fang; Y J Huang; C F Kwok; Y P Hsu; L T Ho
Journal:  Biochem Biophys Res Commun       Date:  1996-10-23       Impact factor: 3.575

Review 3.  The insulin signaling system.

Authors:  M F White; C R Kahn
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

4.  RNAi-based analysis of CAP, Cbl, and CrkII function in the regulation of GLUT4 by insulin.

Authors:  Prasenjit Mitra; Xuexiu Zheng; Michael P Czech
Journal:  J Biol Chem       Date:  2004-07-16       Impact factor: 5.157

5.  Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulin-sensitive tissues.

Authors:  Joseph T Brozinick; Eric D Hawkins; Andrew B Strawbridge; Jeffrey S Elmendorf
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

6.  Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin.

Authors:  Guoli Chen; Priya Raman; Padma Bhonagiri; Andrew B Strawbridge; Guruprasad R Pattar; Jeffrey S Elmendorf
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

7.  Plasma endothelin-1 levels in obese hypertensive and normotensive men.

Authors:  C Ferri; C Bellini; G Desideri; L Di Francesco; R Baldoncini; A Santucci; G De Mattia
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

8.  A 384-well cell-based phospho-ERK assay for dopamine D2 and D3 receptors.

Authors:  Stephen K-F Wong
Journal:  Anal Biochem       Date:  2004-10-15       Impact factor: 3.365

9.  Endothelin-1 inhibits insulin-stimulated glucose uptake in isolated rat adipocytes.

Authors:  Y C Chou; J C Perng; C C Juan; S Y Jang; C F Kwok; W L Chen; J C Fong; L T Ho
Journal:  Biochem Biophys Res Commun       Date:  1994-07-29       Impact factor: 3.575

10.  Phosphatidylinositol 4,5-bisphosphate regulates adipocyte actin dynamics and GLUT4 vesicle recycling.

Authors:  Makoto Kanzaki; Megumi Furukawa; William Raab; Jeffrey E Pessin
Journal:  J Biol Chem       Date:  2004-04-28       Impact factor: 5.157

View more
  10 in total

Review 1.  "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action.

Authors:  Joseph T Brozinick; Bradley A Berkemeier; Jeffrey S Elmendorf
Journal:  Curr Diabetes Rev       Date:  2007-05

2.  Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Kirk M Habegger; Alicia M McCarthy; Lixuan Tackett; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2011-06-28       Impact factor: 4.736

Review 3.  Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis.

Authors:  Nolan J Hoffman; Jeffrey S Elmendorf
Journal:  Trends Endocrinol Metab       Date:  2011-01-07       Impact factor: 12.015

4.  Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol.

Authors:  Guillaume Pare; David Serre; Diane Brisson; Sonia S Anand; Alexandre Montpetit; Gerald Tremblay; James C Engert; Thomas J Hudson; Daniel Gaudet
Journal:  Am J Hum Genet       Date:  2007-02-21       Impact factor: 11.025

5.  Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium.

Authors:  Chaterina Sujana; Veikko Salomaa; Frank Kee; Jochen Seissler; Pekka Jousilahti; Charlotte Neville; Cornelia Then; Wolfgang Koenig; Kari Kuulasmaa; Jaakko Reinikainen; Stefan Blankenberg; Tanja Zeller; Christian Herder; Ulrich Mansmann; Annette Peters; Barbara Thorand
Journal:  Cardiovasc Diabetol       Date:  2022-06-09       Impact factor: 8.949

6.  Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease.

Authors:  Steven Wiltshire; Brenda L Powell; Michelle Jennens; Pamela A McCaskie; Kim W Carter; Lyle J Palmer; Peter L Thompson; Brendan M McQuillan; Joseph Hung; John P Beilby
Journal:  Hum Genet       Date:  2008-02-21       Impact factor: 4.132

Review 7.  Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.

Authors:  Inge A M van den Oever; Hennie G Raterman; Mike T Nurmohamed; Suat Simsek
Journal:  Mediators Inflamm       Date:  2010-06-15       Impact factor: 4.711

8.  Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Emily M Horvath; Kirk M Habegger; Alicia M McCarthy; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

9.  Endothelin-1 reduces glucose uptake in human skeletal muscle in vivo and in vitro.

Authors:  Alexey Shemyakin; Firoozeh Salehzadeh; Daniella Esteves Duque-Guimaraes; Felix Böhm; Eric Rullman; Thomas Gustafsson; John Pernow; Anna Krook
Journal:  Diabetes       Date:  2011-06-15       Impact factor: 9.461

10.  Associations of EDNRA and EDN1 polymorphisms with carotid intima media thickness through interactions with gender, regular exercise, and obesity in subjects in Taiwan: Taichung Community Health Study (TCHS).

Authors:  Tsai-Chung Li; Chia-Ing Li; Li-Na Liao; Chiu-Shong Liu; Chuan-Wei Yang; Chih-Hsueh Lin; Jen-Hao Hsiao; Chih-Yi Hsiao; Wen-Yuan Lin; Fang-Yang Wu; Cheng-Chieh Lin
Journal:  Biomedicine (Taipei)       Date:  2015-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.